ArticleLeukemia2023

Dual intron-targeted CRISPR-Cas9-mediated disruption of the AML RUNX1-RUNX1T1 fusion gene effectively inhibits proliferation and decreases tumor volume in vitro and in vivo.

Signe Neldeborg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.